{
  "paper_id": "PMC7906047",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906047/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Genome-wide HetLOD scores for 11 high-risk primary brain cancer pedigrees combined.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7906047/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/e0b620e543a6/noaa161_fig1.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Fig. 2.",
      "caption": "High-risk primary brain cancer pedigree K5101 showing evidence for linkage on chromosome 16; only descendants connected to genotyped primary brain cancer cases (fully shaded) are shown. *Inferred haplotype carriers.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7906047/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e8a/7906047/38ffc0ba45ef/noaa161_fig2.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Summary genome-wide het-TLODs for both the dominant and recessive models are shown in Figure 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Pedigree-specific linkage results for the dominant model for high-risk primary brain cancer pedigrees\n\n\nChromosome\nPedigree ID\nTLOD\nChromosome Band\n\n\n\n2\nK5100\n+2.29\n2p25.3\n\n\n3\nK5100\n+2.40\n3p26.1\n\n\n14\nK5101\n+1.93\n14q32.32\n\n\n16\nK5101\n+2.44\n16p13.11\n\n\n\nOpen in a new tabThe pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.Table 3.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The pedigree in which the linkage evidence for chromosome 16 was observed is shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type\n\n\nType\nHistology Coding\nObs\nExp\n\nP-value\n\n\n\nAstrocytoma\n9380–82, 9400–1, 9410–11, 9420–1, 9423–24, 9430\n14\n11.7\n0.283\n\n\nGlioblastoma\n9440–9442\n11\n6.7\n0.077\n\n\nOligodendroglioma\n9450–51\n*\n2.3\n0.657\n\n\nEpendymoma\n9391–92\n5\n1.2\n0.0071\n\n\nMedulloblastoma\n9470–71, 9473\n*\n1.8\n0.276\n\n\nOligoastrocytoma\n9382\n*\n0.9\n0.602\n\n\nUnclassified\n\n4\nNA\nNA\n\n\n\nOpen in a new tab\n*Counts <5 censored to protect privacy.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Total primary brain cancers recorded in UPDB in linked pedigree K5101 (Figure 2), by histologic type.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2\n\n\n\nPrimary\nAge at Diagnosis\nSurvival\n\n\nSite\nStage\nYears\nMonths\nHistology\n\n\n\n\n717&\n\n1\n<10\n36–48\n9470-medulloblastoma\n\n\n715\n1\n60–70\n<12\n9391-ependymoma\n\n\nNA\n1\n50–60\n<12\n9440-glioblastoma\n\n\n713* ^\n\n1\n50–60\n<12\n9401-astrocytoma\n\n\n715* &\n\n1\n50–60\n24–36\n9390-choroid plexus carcinoma\n\n\n711*\n1\n>80\n<12\n9440-glioblastoma\n\n\n\nOpen in a new tab\n\nStage 1 = localized.\n* Haplotype sharing cases from linkage analysis.\n\n^ Positive for IDH1.\n\n& Negative for IDH1.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Characteristics of the 6 genotyped primary brain cancer cases in K5101, the chromosome 16-linked pedigree shown in Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 48,
    "images_downloaded": 2,
    "tables_filtered": 17
  }
}